Senior healthcare leaders face a paradox: the organizations most aligned with the nation’s goals for equity, access, and prevention — federally qualified health centers (FQHCs) — still operate on a financing model built for a different era. Population health work is often mislabeled as overhead or “grant‑driven,” yet it sits, in practice, at the operating core of value‑based care. It is the set of capabilities that turns clinical excellence and community trust into performance-based revenue across the full spectrum of payment models: those tied to patient health outcomes, to high-priority process measures such as pediatric well‑child visits, Medicare Annual Wellness Visits (AWVs), and cancer screenings for breast, colorectal, and cervical cancers, and to population-level cost and utilization benchmarks.

Done well, population health positions health centers to align with federal strategy, Medicaid reform, and the Quintuple Aim, and may also provide significant revenue.^1,2,3 In a different policy environment, that sentence could say will, but the past decade has shown how fragile and unpredictable federal ambitions can be. Even so, and perhaps because of that, population health remains essential.

The three‑legged stool is wobbly

The traditional financing foundation for health centers — Section 330 grants, 340B pharmacy savings, and encounter‑based reimbursement (i.e., the three-legged stool) — remains essential but increasingly strained and under threat. Grants fund mission-critical access but cover a fraction of what it costs to deliver today’s primary care. PPS payments reward visits, not the continuous work of managing chronic conditions, integrating behavioral health, or coordinating care across settings. Even 340B, long a stabilizing force supporting enabling services, is subject to policy shifts and manufacturer‑level changes that make it too variable to anchor future sustainability.

Health centers have built remarkable value atop this structure, but the structure itself has not kept pace with the clinical and administrative complexity inherent in caring for high‑need, high‑risk populations. Simply doing more of what worked a decade ago will not secure viability in the years ahead. Most FQHC executives will recognize that I am understating the severity of the situation.

Value-based commitments versus reality

Although federal strategy continues to promote accountable care and value‑based models — including CMS’ updates to the 2025 ACO initiatives and ongoing investments in population‑based programs — many health centers face a contradictory reality at the state and health‑plan level. States and managed‑care organizations frequently retreat from, delay, or defund the very value‑based approaches they previously championed or formally committed to. These reversals erode the financial predictability that health centers need to sustain population health infrastructure.

Across the country, the pattern is familiar: a new model is announced, stakeholders invest in readiness, incentives are established, and then, sometimes abruptly, the initiative stalls or regresses. The instability runs directly counter to evidence showing that Medicaid APMs, when implemented and maintained, improve clinical quality and chronic‑disease outcomes in FQHCs.⁴ Retrenchment directly undermines health centers’ ability to convert strong clinical outcomes into sustainable revenue.

Washington State’s halted progression toward Advanced APMs

Washington State offers a representative example. Over several years, the state pursued a multi‑stage roadmap intended to move FQHCs progressively toward more prospective, population‑based payment tied to quality and cost outcomes.

Based on commitments from state agencies and the broader Medicaid reform agenda, health centers invested substantially in preparation: new clinical workflows, documentation accuracy, care management staffing, and population health data integration. Some, including mine, went considerably further — standing up discrete Population Health departments and hiring Population Health leaders, providers, nurses, medical assistants, community health workers, and clinical quality analysts and navigators.

Yet political tension between the legislature and the Health Care Authority ultimately halted the progression and pushed the field back toward a more fee‑for‑service-weighted methodology. The result was reduced opportunity to earn value‑based revenue and a re‑expansion of encounter‑dependent financing, precisely the opposite direction of the state’s earlier commitments.

Is value‑based care now a fourth leg?

Still, on balance, it appears that federal and state purchasers are continuing to move toward accountable care relationships and population‑based payment.^1,2,5 The strongest case for this shift rests on the realities of rising chronic-disease burden, unsustainable cost trajectories, and structural inequities embedded in the current system. Value‑based care (VBC) recognizes and funds what health centers already do well: prevention, whole‑person care, chronic disease management, and equity-oriented outreach.

Population health is the strategic mechanism that turns these capabilities into measurable value. Tactically, it can improve attribution accuracy, close care gaps, manage high‑risk cohorts, strengthen care transitions, and support behavioral health and social‑needs integration. In value‑based arrangements, these functions directly determine financial performance. They are the infrastructure through which value-based revenue is earned.

Very recently, national policy updates have highlighted additional models — the LEAD ACO Model, the ACCESS Model, and the Rural Health Transformation Program — that share design elements emphasizing long‑term accountability, outcome‑based payment, technology‑enabled care, and integrated care coordination.⁶ For health centers and ACO participants, these programs signal another phase of commitment to population health capabilities as core infrastructure.

CVCH’s population health journey

Ten years ago, population health work at my health center, Columbia Valley Community Health (CVCH), lived everywhere and nowhere. It showed up in reminder lists, in ad‑hoc outreach campaigns, in clinic‑specific quality projects, and in spreadsheets. Intentions were sound, but the work was diffuse. Now it lives everywhere and somewhere. That is, population health moved from a set of fragmented, patchwork tasks to defined operational and programmatic functions, with centralized leadership, analytic discipline, and roles that complement rather than interrupt primary care.

Today, CVCH’s Population Health Department remains compact but designed for the realities of value‑based care. The department is led by a manager who serves as strategist and integrator, connecting payer expectations, ACO participation, empanelment, quality metrics, and social needs initiatives into a single, coherent function. She ensures CVCH has the workflows, data, and teams needed to carry out what those agreements require. She is the fulcrum between population‑level strategy and day‑to‑day clinic operations.

The analytic foundation is handled by informatics contractors, an internal analyst, and quality navigators who vet, monitor, and steward dashboards, UDS reviews, enrollment, risk adjustment trending, and other quality data that allow leaders to track performance on key process and outcome measures. An informatics‑developed tool houses actionable reports, quality metrics, operational lists, and performance dashboards.

Quality navigators operate at the intersection of data and clinic workflow. They refine actionable lists, validate attribution and empanelment, reconcile payer rosters, and turn population‑level metrics into practical operational tasks. Their work ensures accurate, timely information about which patients are overdue for screening, where care gaps remain unresolved, and where diagnosis accuracy, risk-adjustment completeness, or documentation corrections are needed.

Population Health’s clinical staff extend the reach of primary care in two ways. First, through a centralized service model, Population Health APPs, RNs, and community health workers (CHWs) deliver key preventative and chronic‑care services: AWVs, transitional care contacts, medication reconciliation tied to chronic‑disease control, SDoH assessments, and focused management of high‑risk patients. Centralizing these capabilities allows CVCH to deploy them where gaps are greatest and where value‑based contracts place the most weight.

Second, the Population Health team equips primary care providers and care teams directly, training clinicians on measure expectations, risk adjustment accuracy, documentation standards, SDoH workflows, depression screening procedures, and the operational strategies that improve performance. They help teams understand their data, refine their processes, and recognize the population‑level impact of everyday clinical decisions. This structure ensures that population health is not something just done “over here” by a separate team. And certainly at CVCH, it is a work in progress. On our best days, and increasingly, it is an integrated lens applied across CVCH’s entire primary care system.

CHWs complete the continuum by managing social needs assessments, care plans, and connections to community resources. Their work anchors the equity and whole‑person dimensions of population health, ensuring that improvements in clinical metrics are paired with practical interventions addressing food insecurity, housing instability, financial stress, and other barriers that shape outcomes.

The result is an operating model built for value‑based care: analytics to define the landscape, navigators to operationalize it, clinical staff to act on it, CHWs to address the social dimensions of health, and leadership to ensure alignment with payer expectations and organizational strategy. CVCH’s population health team performs the work that makes VBC contracts succeed. Its influence is larger than its size because it sits at the hinge point of quality, patient experience, equity, and organizational sustainability.

In other words, the investment has demonstrated value. A high-performing team operating from a coherent strategic framework positions us to adapt as conditions change. CVCH’s experience demonstrates why internal population health capacity must be built to withstand both forward‑looking innovation and sudden policy reversals.

The future, though, is genuinely uncertain. Organizations of every kind depend on predictability, and the number of unsettled variables at play right now — policy, funding, political will — exceeds what most planning cycles are built to absorb. Health centers are near-universally struggling to set and hold a strategic course these days. CVCH is no exception.

Equity and workforce

Before the evolution toward equity and workforce well‑being, the Institute for Healthcare Improvement’s Triple Aim provided a foundational framework: improving population health, enhancing the patient experience, and reducing per‑capita cost. Over time, it became clear that these aims depended on two additional factors, equity and workforce stability, leading to the development of the Quintuple Aim.

The evolution from the Triple Aim to the Quintuple Aim added explicit attention to equity and workforce well‑being, two domains that deeply influence the performance of safety‑net organizations.³ Health centers have always centered their work on reducing disparities and serving diverse communities. With population health infrastructure in place, they can make those commitments measurable.

Stratifying data by race, ethnicity, language, disability, and geography reveals where gaps exist and where interventions can have the greatest impact. As examples, integrating behavioral health and deploying CHWs strengthens care teams in ways that improve outcomes and reduce clinician burden. These practical steps help advance patient health for all patients — including the marginalized — and support workforce stability, aims now embedded in national strategy.

Medicaid: The financial center of gravity

Because Medicaid represents the majority of payer mix for most health centers, its purchasing strategies shape organizational survival. Preserving the PPS floor remains essential, and federal guidance maintains states’ obligations to deliver wrap payments when managed-care reimbursement falls short of the PPS rate.⁷ At the same time, Medicaid agencies are adopting alternative payment models (APMs) that supplement PPS with prospective payments and outcomes‑based incentives.

Emerging federal models referenced in recent policy updates, including the ACCESS Model and the Rural Health Transformation Program⁶, reflect this trajectory by elevating integrated coordination and accountability expectations that align closely with health centers’ population health strengths.

Despite CMS’ continued shift toward accountable care and population‑based models at the federal level, state Medicaid APM commitments remain fragile. APMs are optional for states, and their continuation depends on political will, legislative appropriations, and agency capacity. Even though evidence shows that Medicaid APMs improve hypertension and diabetes outcomes in FQHCs, states frequently pause implementation, modify incentive structures, shrink prospective payment components, or revert to simpler encounter‑based arrangements when budget pressure or leadership turnover emerges. As noted earlier, this instability creates operational and financial risk for health centers that have already made long‑term population health investments based on prior state commitments.

Successful health centers treat these arrangements as opportunities to fund the non‑visit work that PPS alone cannot sustain. The strongest performers do not chase every metric; they focus on the outcomes that drive both clinical impact and financial return — namely, chronic disease control, cancer screening, immunization rates, depression response, and timely transitions of care.

The cost benchmark trap

For many health centers, particularly those operating in regions with high hospital prices, participation in more progressive upside‑ and downside‑risk value‑based arrangements is blocked long before quality performance is considered. Financial benchmarks and medical‑loss‑ratio (MLR) thresholds are built on regional total cost of care, including inpatient and outpatient hospital charges that FQHCs do not control. For example, CMS’ own ACO REACH financial methodology makes clear that benchmarks incorporate all Medicare Part A and Part B expenditures, including hospital spending. The same is true for many value-based care contract arrangements with state-based Medicaid MCO health plans.

In markets where hospital systems set prices far above state or national averages, these costs become baked into the benchmark. Analyses by Milliman⁸ demonstrate that regional variation in hospital unit‑cost trends can work significantly for or against ACOs depending on county‑level cost dynamics — effects that may disadvantage organizations in higher‑cost regions even when their own performance is strong. Health Affairs has further emphasized that meeting or missing a benchmark often reflects regional price dynamics rather than the success of care delivery interventions.⁹

The result is a structural paradox: health centers can excel on process measures — well‑child visits, Medicare AWVs, cancer screenings — and even improve intermediate outcomes yet still fail the cost threshold required to share in savings or qualify for reinvestment capital. FQHCs that deliver high‑quality preventive and chronic‑care management may be locked out of the very value‑based models designed to reward such performance.

This dynamic not only suppresses participation; it weakens long‑term incentives for health centers to invest in population health capacity. A system that ties FQHC financial opportunity to hospital pricing, rather than to primary‑care‑driven performance, cannot credibly claim to be supporting sustainable, community‑based value‑based care.

Until value‑based models decouple FQHC incentives from regional hospital pricing, health centers will continue to face barriers unrelated to care quality, efficiency, or even population health performance.

Medicare: Accountability through primary care

Medicare’s evolution mirrors Medicaid’s. Through the Medicare Shared Savings Program (MSSP) and the ACO REACH model, CMS continues to emphasize strong primary care attachment, reduced avoidable utilization, coordinated transitions, and improved patient experience.^1,5 These models reward disciplined population management, and FQHCs possess strengths well aligned with those expectations.

Attribution accuracy and transitions-of-care management in particular play outsized roles in determining shared‑savings performance. Investments in population health infrastructure pay off twice: they support mission, and they stabilize revenue.

Recent federal discussions of the LEAD ACO Model are directionally consistent with this emphasis on coordinated, accountable primary care.⁶

A strategic path forward

Population health is the platform that connects mission to a more complete payment portfolio. It can be understood as bracing added to the traditional three‑legged stool — or as a fourth leg altogether. Either way, once fully built, it steadies what is otherwise being steadily chipped away.

It is both smart and necessary to make long‑term investments in population health and build a robust value‑based care portfolio — one that reinforces what health centers already do well: coordinate care, advance equity, and serve communities with continuity and trust.

The most effective health centers now design strategy, negotiations, and operations around population health infrastructure. This work is the lever that enables mission‑driven providers to succeed in an environment where payers increasingly purchase outcomes, not encounters.

The reality health centers must plan for

The path forward cannot rely on a linear policy trajectory or uninterrupted value‑based reform. It must instead rest on population‑health infrastructure resilient enough to withstand state‑level reversals, payer retrenchment, and federal shifts in emphasis. Value‑based care is not only a revenue opportunity; it is a stabilizing counterweight to the volatility built into public‑payer policy.

Health centers that anchor their strategy in population health — not in the shifting promises of payment reform — are best positioned to protect mission, advance equity, and sustain operations through political and contractual disruption.

Federal models will evolve. State priorities will shift. Payers will continue to balance policy incentives against economic pressures. But one constant remains: across administrations and party lines, there is enduring support for improving care processes, strengthening outcomes, and reducing avoidable costs. These are the very aims population health advances and why it remains the most durable ground on which health centers can stand. Not because policy is predictable, but because its underlying goals have proven more stable than the vehicles used to pursue them.

Notes:

1. Centers for Medicare & Medicaid Services. "CMS Moves Closer to Accountable Care Goals with 2025 ACO Initiatives." Jan. 15, 2025. Available from: https://www.cms.gov/newsroom/fact-sheets/cms-moves-closer-accountable-care-goals-2025-aco-initiatives
2. Centers for Medicare & Medicaid Services; Center for Medicare & Medicaid Innovation. "Testimony on Evaluating the Shift to Value‑Based Care (Liz Fowler, PhD, JD)." Statement before the U.S. House Committee on Energy and Commerce; 2024 Jun 13. Available from: https://www.hhs.gov/about/agencies/asl/testimony/2024/06/13/checking-in-on-cmmi-assessing-the-transition-to-value-based-care.html
3. Nundy S, Cooper LA, Mate KS. "The Quintuple Aim for Health Care Improvement: A New Imperative to Advance Health Equity." JAMA. 2022;327(6):521‑522. Available from: https://jamanetwork.com/journals/jama/article-abstract/2788483
4. Markowski J, Wallace J, Schlesinger M, et al. "Alternative payment models and performance in federally qualified health centers." JAMA Intern Med. 2024;184(9):1065‑1073. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821079
5. Centers for Medicare & Medicaid Services. "ACO REACH Model. 2023–2025." Available from: https://www.cms.gov/priorities/innovation/innovation-models/aco-reach
6. Masucci A, Wiefling B, Miller A. "Federal healthcare policy updates: planning for success in 2026–2027." COPE Health Solutions. Jan. 15, 2026. Available from: https://copehealthsolutions.com/cblog/federal-healthcare-policy-updates-planning-for-success-in-2026-2027/
7. Centers for Medicare & Medicaid Services. "State Health Official Letter #16‑006: FQHC and RHC Supplemental Payment Requirements under Medicaid Managed Care." April 26, 2016. Available from: https://www.medicaid.gov/federal-policy-guidance/downloads/SMD16006.pdf
8. Kramer E, Li C, Snyder A. "Recent changes to ACO REACH financial benchmark methodology to account for PY 2024 fee schedule changes." Milliman. Dec. 7, 2023. Available from: https://www.milliman.com/en/insight/recent-changes-to-aco-reach-financial-benchmark-methodology-to-account-for-PY-2024-fee-schedule
9. Ryan AM, Markovitz AA, Rooke-Ley H. “'All I do is win': why beating benchmarks doesn’t mean that ACOs are reducing costs." Health Aff Forefront. April 15, 2025. Available from: https://www.healthaffairs.org/content/forefront/all-do-win-why-beating-benchmarks-doesn-t-mean-acos-reducing-costs